DUGOTRAJNA UPOTREBA BENZODIAZEPINA KOD PACIJENATA SA POREMEĆAJEM LIČNOSTI I KOD PACIJENATA BEZ POREMEĆAJA LIČNOSTI
Sažetak
Poremećaji ličnosti predstavljaju veoma česta komorbidna stanja kod zavisnika. Cilj ove studije bio je da, uzimajući u obzir prisustvo ili odsustvo poremećaja ličnosti, utvrdi da li dugotrajna, kontinuirana upotreba benzodiazepina (duža od jedne godine) dovodi do razvoja simptoma zavisnosti. U ispitanoj grupi bilo je 78 osoba koje su koristile benzodiazepin kao monoterapiju najmanje jednu godinu pre skrininga. Pacijenti su popunjavali grupu upitnika: polustrukturisani upitnik za sociodemografske podatke i za osnovne podatke o upotrebi benzodiazepina, Viskonsin upitnik za procenu ličnosti i samoupitnik o zavisnosti od benzodiazepina. Grupa je potom podeljena u dve podgrupe: grupu ispitanika sa poremećajima ličnosti (60,26%) i grupu ispitanika bez poremećaja ličnosti (39,74%). Pri poređenju ovih dveju grupa u obzir su uzeti korelat zavisnosti od benzodiazepina (problematična upotreba benzodiazepina, preokupacija benzodiazepinima, nedostatak komplijanse i apstinencijalni sindrom) i intenzitet zavisnosti od benzodiazepina. Kod oko 70% svih ispitanika zapaženi su pozitivni pokazatelji fizičke zavisnosti (nedostatak komplijanse zbog porasta tolerancije kod 73,08% ispitanika i apstinencijalni sindrom kod 70,51% ispitanika). Pokazatelj psihološke zavisnosti (preokupacija benzodiazepinima) bio je pozitivan kod 94,87% ispitanika, a pokazatelj socijalnih aspekata zavisnosti (problematična upotreba benzodiazepina) kod 93,59% ispitanika. Ukupan skor, tj. intenzitet zavisnosti od benzodiazepinа, bio je na statistički značajnom nivou veći u grupi ispitanika sa poremećajem ličnosti. Kod pacijenata sa poremećajem ličnosti zabeleženi su češća i intenzivnija preokupacija benzodiazepinima i nedostatak komplijanse. Istovremena pojava dvaju ili više poremećaja ličnosti povećava intenzitet preokupacije benzodiazepinom.
Reference
Andrews G. Comorbidity and the general neurotic syndrome. The British Journal of Psychiatry 1996;168(S30):76-84. [CrossRef][PubMed]
Baillie AJ, Mattick RP. The benzodiazepine dependence questionnaire: development, reliability and validity. The British Journal of Psychiatry 1996;169(3): 276-81. [CrossRef][PubMed]
Canham SL, Gallo J, Simoni-Wastila L. Perceptions of benzodiazepine dependence among women age 65 and older. Journal of gerontological social work 2014;57(8):872-88. [CrossRef][PubMed]
de las Cuevas C, Sanz E, de la Fuente J. Benzodiazepines: more" behavioural" addiction than dependence. Psychopharmacology 2003;167:297-303. [CrossRef][PubMed]
Edinoff AN, Nix CA, Hollier J, Sagrera CE, Delacroix BM, Abubakar T, et al. Benzodiazepines: uses, dangers, and clinical considerations. Neurology international 2021;13(4):594-607. [CrossRef][PubMed]
Fraser R, Isaif L, Teles D, Laporte L. Personality Disorders and Addiction Disorders. In: el-Guebaly N, Carra G, Galanter M, Baldacchino AM, editors. Textbook of Addiction Treatment: International Perspectives. New York City: Springer; 2021. p. 1373-89. [CrossRef]
Goretti S, Sanchéz MS, Borja PL, Rivera GB, Lara MR. The relationship between personality disorders and substance abuse disorders. European Psychiatry 2017;41(S1):S473-4. [CrossRef]
Kan CC, Breteler MH, Timmermans EA, Van der Ven AH, Zitman FG. Scalability, reliability, and validity of the benzodiazepine dependence self-report questionnaire in outpatient benzodiazepine users. Comprehensive psychiatry 1999;40(4):283-91. [CrossRef][PubMed]
Klein MH, Benjamin LS, Rosenfeld R, Treece C, Husted J, Greist JH. The Wisconsin personality disorders inventory: Development, reliability, and validity. Journal of Personality Disorders 1993;7(4):285-303. [CrossRef]
Konopka A, Wysiecka JP, Samochowiec J. Benzodiazepine misuse and addiction. Risk factors and adverse behavioral aspects. In: Preedy VR, editor. Neuropathology of drug addictions and substance misuse, Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. Cambridge (Massachusetts): Academic Press; 2016. p. 327-33. [CrossRef]
Manthey L, Lohbeck M, Giltay EJ, Veena T, Zitman FG, Penninx BW. Correlates of benzodiazepine dependence in the Netherlands Study of Depression and Anxiety. Addiction 2012;107(12):2173-82. [CrossRef][PubMed]
Nordfjærn T, Bjerkeset O, Moylan S, Berk M, Gråwe RW. Clusters of personality traits and psychological symptoms associated with later benzodiazepine prescriptions in the general population: The HUNT Cohort Study. Addictive Behaviors 2013;38(10):2575-80. [CrossRef][PubMed]
Petursson H, Lader MH. Benzodiazepine dependence. British Journal of Addiction 1981;76(2):133-45. [CrossRef][PubMed]
Salzman C, Balter M, Ellinwood E, Gallant DM, Gillin JC, Greenblatt DJ, et al. American Psychiatric Association task force on benzodiazepine dependency, toxicity, and abuse. Washington: American Psychiatric Press; 1990.
Schneider Jr R, Ottoni GL, Carvalho HW, Elisabetsky E, Lara DR. Temperament and character traits associated with the use of alcohol, cannabis, cocaine, benzodiazepines, and hallucinogens: evidence from a large Brazilian web survey. Brazilian Journal of Psychiatry 2015;37:31-9. [CrossRef][PubMed]
Schweizer E, Rickels K, De Martinis N, Case G, Garcia-Espana F. The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients. Psychological Medicine 1998;28(3):713-20. [CrossRef][PubMed]
Smith TL, Klein MH, Benjamin LS. Validation of the Wisconsin personality disorders inventory-IV with the SCID-II. Journal of Personality Disorders 2003;17(3):173-87. [CrossRef][PubMed]
Uhlenhuth EH, DeWit HA, Balter MB, Johanson CE, Mellinger GD. Risks and benefits of long-term benzodiazepine use. Journal of Clinical Psychopharmacology 1988;8(3):161-7. [CrossRef][PubMed]
Umbricht A, Velez ML. Benzodiazepine and nonbenzodiazepine hypnotics (z-drugs): the other epidemic. In: el-Guebaly N, Carra G, Galanter M, Baldacchino AM, editors. Textbook of Addiction Treatment: International Perspectives. New York City: Springer; 2021. p. 141-56. [CrossRef]
Votaw VR, Geyer R, Rieselbach MM, McHugh RK. The epidemiology of benzodiazepine misuse: a systematic review. Drug and alcohol dependence 2019;200:95-114. [CrossRef][PubMed]
